Work

Correction: Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance

Year: 2023

Type: erratum

Source: Oncogene

DOI: 10.1038/s41388-023-02832-1

Authors: R. I. Cordo Russo, W. Béguelin, M. C. Díaz Flaqué, C. J. Proietti, L. Venturutti, N. Galigniana, M. Tkach, P. Guzmán, J. C. Roa, N. A. O’Brien, E. H. Charreau, R. Schillaci, P. V. Elizalde

Institutions: Consejo Nacional de Investigaciones Científicas y Técnicas, Experimental Medicine and Biology Institute, Universidad de La Frontera, University of California, Los Angeles

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4386536620

Cites:

Cited by:

Related to: 10